Intra-corneal Implant
Keratoconus
Key Facts
About MAG Optics
MAG Optics is a private, pre-revenue medical device innovator developing a novel intra-corneal implant platform to treat Keratoconus and other refractive errors. Founded in 2003 and based in Rochester, NY, the company's approach aims to transform irregular corneas by applying personalized biomechanical forces, addressing a significant unmet clinical need. The technology has shown promise in early data for improving corneal regularity and alignment, and the company has gained recognition through awards and residency at Johnson & Johnson Innovation JLABS.
View full company profileAbout MAG Optics
MAG Optics is a private, pre-revenue medical device innovator developing a novel intra-corneal implant platform to treat Keratoconus and other refractive errors. Founded in 2003 and based in Rochester, NY, the company's approach aims to transform irregular corneas by applying personalized biomechanical forces, addressing a significant unmet clinical need. The technology has shown promise in early data for improving corneal regularity and alignment, and the company has gained recognition through awards and residency at Johnson & Johnson Innovation JLABS.
View full company profileTherapeutic Areas
Other Keratoconus Drugs
| Drug | Company | Phase |
|---|---|---|
| IVMED-80 | iVeena Delivery Systems | Phase 2/3 (assumed post-ODD) |